Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601485-25-000124
Filing Date
2025-11-13
Accepted
2025-11-13 16:08:50
Documents
83
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q angn-20250930.htm   iXBRL 10-Q 1083374
2 EX-31.1 elicio10-qxexhibit311.htm EX-31.1 4385
3 EX-31.2 elicio10-qxexhibit312.htm EX-31.2 4409
4 EX-32.1 elicio10-qxexhibit321.htm EX-32.1 1624
5 EX-32.2 elicio10-qxexhibit322.htm EX-32.2 1651
11 elicio10-qxexhibit311001.jpg GRAPHIC 225028
12 elicio10-qxexhibit311002.jpg GRAPHIC 66177
13 elicio10-qxexhibit312001.jpg GRAPHIC 224747
14 elicio10-qxexhibit312002.jpg GRAPHIC 68371
15 elicio10-qxexhibit321001.jpg GRAPHIC 95943
16 elicio10-qxexhibit322001.jpg GRAPHIC 98170
  Complete submission text file 0001601485-25-000124.txt   7710846

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20250930.xsd EX-101.SCH 52923
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT angn-20250930_cal.xml EX-101.CAL 61564
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT angn-20250930_def.xml EX-101.DEF 243705
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20250930_lab.xml EX-101.LAB 649484
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20250930_pre.xml EX-101.PRE 476800
86 EXTRACTED XBRL INSTANCE DOCUMENT angn-20250930_htm.xml XML 781828
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39990 | Film No.: 251478485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)